Expert Profile
Using AI to improve outcomes and profitability:
Practical guidance on where AI can realistically improve performance, efficiency, and margins.
Making smart technology decisions in regulated environments:
Helping leaders understand how to adopt AI responsibly in healthcare, senior care, insurance, and other highly regulated industries.
Operational use cases that actually work today:
Identifying AI applications already delivering measurable results
Executive alignment around AI and automation:
Supporting leadership teams in getting aligned on priorities, risk tolerance, investment levels, and timing.
New revenue opportunities enabled by technology:
Exploring how AI can enable new services, pricing models, or growth strategies.
Board and leadership briefings on AI risk and opportunity:
Clear, non-technical briefings focused on competitive impact, near-term risks, and what leaders need to decide now.
How AI Will Reshape Home Health Care – YouTube
Robin’s Book “How AI Can Democratize Healthcare”
Robin has delivered over 200 keynotes across 16 countries, including engagements with UnitedHealthcare and its 150 largest partner companies, the Department of Defense and the White House, as well as major pharmaceutical organizations such as Roche.
Robin Farmanfarmaian is a professional keynote speaker, author, and healthcare entrepreneur who helps leaders make sense of cutting-edge technologies so they can improve patient outcomes, stay competitive, and increase revenue.
She is the co-founder and CEO of ChiroScript AI, a generative AI medical scribe. She serves as an advisor to multiple healthcare technology companies, including Luxsonic, a virtual-reality platform for radiology; iSono Health, a portable, AI-driven ultrasound device for breast cancer detection; CompanionIQ, an AI companion for post-surgical patients, seniors, and veterans; and VitaKavana, focused on cutting edge longevity for families.
With more than 225 keynotes delivered across 16 countries, Robin’s talks focus on the real-world impact of AI, digital health, and emerging medical technologies, particularly how care is shifting from traditional clinical settings into 24/7 care. She is known for translating complex innovation into clear, actionable insights leaders can apply immediately.
Robin has spoken for many of the world’s most influential healthcare and technology organizations, including UnitedHealthcare, Roche, Procter & Gamble, Kaiser Permanente, Blue Cross Blue Shield, Verily, Abbott, Boston Scientific, Humana, Takeda, Stanford Hospital, Harvard’s Massachusetts General Hospital, ARPA-H, and The White House.
She is the author of four books, including The Patient as CEO: How Technology Empowers the Healthcare Consumer and How AI Can Democratize Healthcare: The Rise in Digital Care, and is widely recognized for bringing both business rigor and lived patient experience to the future of healthcare.
